Mara P. Steinkamp’s research focuses on targeted therapies for ovarian cancer treatment using patient-derived models of disseminated ovarian cancer.
Mara P. Steinkamp’s research focuses on targeted therapies for ovarian cancer treatment using patient-derived models of disseminated ovarian cancer. Dr. Steinkamp is particularly interested in targeting the ErbB family of receptor tyrosine kinases that are co-expressed in ovarian cancer. The Steinkamp lab uses 2D and 3D bioluminescent and fluorescent in vivo imaging in mouse models to quantify disseminated tumor burden over time.
With our growing understanding of the role of tumor-associated immune cells in cancer growth and response to therapies, Dr. Steinkamp has characterized Ovarian Cancer patient-derived xenograft (PDX) growth in mice with a reconstituted human immune system.
Mara P. Steinkamp, Ph.D.
Assistant Professor, Department of Pathology
Postdoctoral Training, University of New Mexico (Bridget S. Wilson and Diane S. Lidke Labs), 2009-2004
Ph.D. in Human Genetics, University of Michigan (Diane Robins Lab), 2009
B.A. in Biology and English, Williams College, 1998
Mara P. Steinkamp Ph.D.
Department of Pathology
Cancer Research Facility, Room 205A
University of New Mexico School of Medicine
Albuquerque, New Mexico 87131
Email: msteinkamp@salud.unm.edu
Phone: (505) 272-7684 (office)
Fax: (505) 272-1435